Loading...

FITC anti-mouse CD8a Antibody FITC anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6.7_FITC_102110
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
  • 53-6.7_FITC_102110
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100705 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100706 500 µg DKK589
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  2. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  3. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  4. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  5. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  6. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  7. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  8. Liu J, et al. 2019. Immunity. 50:600. PubMed
  9. Milanovic M, et al. 2021. Cancer Res. 81:426. PubMed
  10. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  11. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  12. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  13. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  14. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  15. Chowdhury S, et al. 2022. Cancer Res. 82:2640. PubMed
  16. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  17. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  18. Deng P, et al. 2022. J Clin Invest. 132: . PubMed
  19. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  20. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  21. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  22. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  23. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  24. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  25. Wang L, et al. 2022. Nutrients. 15: . PubMed
  26. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  27. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  28. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  29. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  30. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  31. Milanovic M, et al. 2021. J Immunol. 206:1228. PubMed
  32. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  33. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  34. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  35. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  36. Lee KM, et al. 2022. Cancer Immunol Res. 10:829. PubMed
  37. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  38. Alghamri MS, et al. 2022. ACS Nano. 16:8729. PubMed
  39. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  40. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  41. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  42. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  43. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  44. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  45. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  46. Bhatia V, et al. 2023. Nat Commun. 14:2041. PubMed
  47. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  48. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  49. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  50. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  51. Park HJ, et al. 2023. NPJ Vaccines. 8:84. PubMed
  52. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  53. Pagano G, et al. 2023. Haematologica. . PubMed
  54. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
  55. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  56. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  57. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  58. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  59. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  60. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  61. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  62. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  63. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  64. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  65. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  66. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  67. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  68. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  69. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  70. Apte S, et al. 2010. J Immunol. 185:998. PubMed
  71. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  72. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  73. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  74. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  75. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  76. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  77. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  78. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  79. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  80. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  81. Treger RS, et al. 2020. Immunity. 50(2):334-347.e9.. PubMed
  82. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  83. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  84. Wu K, et al. 2021. Aging (Albany NY). 13:. PubMed
  85. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  86. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  87. Lutes LK, et al. 2021. eLife. 10:00. PubMed
  88. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  89. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  90. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  91. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  92. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  93. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  94. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  95. Morales D, et al. 2015. J Virol. 89:337. PubMed
  96. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  97. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  98. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  99. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  100. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  101. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  102. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  103. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  104. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  105. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  106. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  107. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  108. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  109. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  110. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  111. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  112. Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed
  113. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  114. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  115. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  116. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  117. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  118. Wu J, et al. 2020. Immunity. 53:115. PubMed
  119. Köchl R, et al. 2020. Elife. 9:00. PubMed
  120. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  121. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  122. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  123. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  124. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  125. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  126. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  127. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  128. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  129. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  130. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  131. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  132. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  133. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  134. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  135. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  136. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  137. Yang J, et al. 2020. Nature. 586:572. PubMed
  138. Wan X, et al. 2018. Nature. 560:107. PubMed
  139. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  140. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  141. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  142. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  143. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  144. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  145. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  146. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  147. Du J, et al. 2018. AMB Express. 8:158. PubMed
  148. Holman P, et al. 2005. J Immunol. 174:3986. PubMed
  149. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  150. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  151. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  152. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  153. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  154. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  155. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  156. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  157. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  158. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  159. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  160. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  161. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  162. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  163. Jin C, et al. 2022. Oncoimmunology. 11:2099642. PubMed
  164. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  165. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  166. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  167. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  168. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  169. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  170. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  171. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  172. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  173. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  174. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  175. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  176. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  177. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  178. Riedl P, et al. 2009. J Immunol. 183:370. PubMed
  179. Zhan L, et al. 2022. Cancer Lett. 529:37. PubMed
  180. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  181. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  182. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  183. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  184. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  185. Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed
  186. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  187. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  188. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  189. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  190. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  191. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  192. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  193. Kvell K, et al. 2014. Immunobiology. 219:644. PubMed
  194. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  195. Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed
  196. Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed
  197. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  198. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  199. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  200. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  201. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  202. Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed
  203. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  204. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  205. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  206. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  207. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  208. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  209. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  210. Ren Y, et al. 2021. Nat Commun. 12:5405. PubMed
  211. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  212. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  213. Royzman D, et al. 2019. Front Immunol. 10:633. PubMed
  214. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  215. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  216. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  217. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  218. Petriv N, et al. 2021. Oncoimmunology. 10:1874159. PubMed
  219. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  220. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  221. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  222. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  223. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  224. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  225. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  226. Li H, et al. 2022. iScience. 25:104481. PubMed
  227. Wang X, et al. 2022. Elife. 11:. PubMed
  228. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  229. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  230. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  231. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  232. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  233. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  234. Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed
  235. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  236. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  237. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  238. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  239. D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed
  240. Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed
  241. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  242. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  243. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  244. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  245. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  246. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  247. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  248. Xie L, et al. 2020. Infect Immun. :88. PubMed
  249. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  250. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  251. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  252. Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed
  253. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  254. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  255. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  256. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  257. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  258. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  259. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  260. Liu J, et al. 2019. Immunity. 50:600. PubMed
  261. Milanovic M, et al. 2021. Cancer Res. 81:426. PubMed
  262. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  263. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  264. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  265. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  266. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  267. Chowdhury S, et al. 2022. Cancer Res. 82:2640. PubMed
  268. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  269. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  270. Deng P, et al. 2022. J Clin Invest. 132: . PubMed
  271. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  272. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  273. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  274. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  275. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  276. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  277. Wang L, et al. 2022. Nutrients. 15: . PubMed
  278. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  279. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  280. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  281. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  282. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  283. Milanovic M, et al. 2021. J Immunol. 206:1228. PubMed
  284. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  285. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  286. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  287. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  288. Lee KM, et al. 2022. Cancer Immunol Res. 10:829. PubMed
  289. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  290. Alghamri MS, et al. 2022. ACS Nano. 16:8729. PubMed
  291. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  292. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  293. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  294. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  295. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  296. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  297. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  298. Bhatia V, et al. 2023. Nat Commun. 14:2041. PubMed
  299. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  300. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  301. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  302. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  303. Park HJ, et al. 2023. NPJ Vaccines. 8:84. PubMed
  304. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  305. Pagano G, et al. 2023. Haematologica. . PubMed
  306. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
  307. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  308. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  309. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  310. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  311. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  312. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  313. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  314. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  315. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  316. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  317. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  318. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  319. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  320. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  321. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  322. Apte S, et al. 2010. J Immunol. 185:998. PubMed
  323. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  324. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  325. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  326. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  327. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  328. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  329. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  330. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  331. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  332. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  333. Treger RS, et al. 2020. Immunity. 50(2):334-347.e9.. PubMed
  334. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  335. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  336. Wu K, et al. 2021. Aging (Albany NY). 13:. PubMed
  337. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  338. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  339. Lutes LK, et al. 2021. eLife. 10:00. PubMed
  340. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  341. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  342. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  343. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  344. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  345. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  346. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  347. Morales D, et al. 2015. J Virol. 89:337. PubMed
  348. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  349. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  350. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  351. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  352. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  353. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  354. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  355. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  356. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  357. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  358. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  359. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  360. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  361. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  362. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  363. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  364. Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed
  365. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  366. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  367. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  368. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  369. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  370. Wu J, et al. 2020. Immunity. 53:115. PubMed
  371. Köchl R, et al. 2020. Elife. 9:00. PubMed
  372. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  373. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  374. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  375. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  376. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  377. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  378. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  379. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  380. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  381. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  382. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  383. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  384. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  385. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  386. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  387. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  388. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  389. Yang J, et al. 2020. Nature. 586:572. PubMed
  390. Wan X, et al. 2018. Nature. 560:107. PubMed
  391. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  392. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  393. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  394. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  395. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  396. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  397. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  398. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  399. Du J, et al. 2018. AMB Express. 8:158. PubMed
  400. Holman P, et al. 2005. J Immunol. 174:3986. PubMed
  401. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  402. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  403. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  404. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  405. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  406. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  407. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  408. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  409. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  410. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  411. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  412. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  413. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  414. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  415. Jin C, et al. 2022. Oncoimmunology. 11:2099642. PubMed
  416. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  417. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  418. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  419. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  420. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  421. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  422. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  423. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  424. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  425. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  426. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  427. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  428. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  429. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  430. Riedl P, et al. 2009. J Immunol. 183:370. PubMed
  431. Zhan L, et al. 2022. Cancer Lett. 529:37. PubMed
  432. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  433. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  434. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  435. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  436. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  437. Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed
  438. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  439. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  440. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  441. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  442. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  443. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  444. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  445. Kvell K, et al. 2014. Immunobiology. 219:644. PubMed
  446. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  447. Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed
  448. Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed
  449. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  450. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  451. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  452. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  453. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  454. Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed
  455. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  456. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  457. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  458. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  459. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  460. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  461. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  462. Ren Y, et al. 2021. Nat Commun. 12:5405. PubMed
  463. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  464. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  465. Royzman D, et al. 2019. Front Immunol. 10:633. PubMed
  466. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  467. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  468. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  469. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  470. Petriv N, et al. 2021. Oncoimmunology. 10:1874159. PubMed
  471. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  472. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  473. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  474. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  475. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  476. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  477. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  478. Li H, et al. 2022. iScience. 25:104481. PubMed
  479. Wang X, et al. 2022. Elife. 11:. PubMed
  480. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  481. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  482. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  483. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  484. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  485. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  486. Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed
  487. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  488. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  489. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  490. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  491. D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed
  492. Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed
  493. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  494. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  495. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  496. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  497. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  498. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  499. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  500. Xie L, et al. 2020. Infect Immun. :88. PubMed
  501. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  502. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  503. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  504. Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed
RRID
AB_312744 (BioLegend Cat. No. 100705)
AB_312745 (BioLegend Cat. No. 100706)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
FITC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
APC anti-mouse CD8a 53-6.7 FC
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01/21/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6.7_FITC_102110
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
  • 53-6.7_FITC_102110
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100705 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100706 500 µg DKK589
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  2. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  3. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  4. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  5. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  6. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  7. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  8. Liu J, et al. 2019. Immunity. 50:600. PubMed
  9. Milanovic M, et al. 2021. Cancer Res. 81:426. PubMed
  10. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  11. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  12. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  13. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  14. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  15. Chowdhury S, et al. 2022. Cancer Res. 82:2640. PubMed
  16. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  17. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  18. Deng P, et al. 2022. J Clin Invest. 132: . PubMed
  19. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  20. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  21. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  22. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  23. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  24. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  25. Wang L, et al. 2022. Nutrients. 15: . PubMed
  26. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  27. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  28. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  29. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  30. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  31. Milanovic M, et al. 2021. J Immunol. 206:1228. PubMed
  32. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  33. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  34. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  35. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  36. Lee KM, et al. 2022. Cancer Immunol Res. 10:829. PubMed
  37. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  38. Alghamri MS, et al. 2022. ACS Nano. 16:8729. PubMed
  39. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  40. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  41. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  42. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  43. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  44. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  45. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  46. Bhatia V, et al. 2023. Nat Commun. 14:2041. PubMed
  47. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  48. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  49. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  50. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  51. Park HJ, et al. 2023. NPJ Vaccines. 8:84. PubMed
  52. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  53. Pagano G, et al. 2023. Haematologica. . PubMed
  54. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
  55. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  56. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  57. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  58. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  59. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  60. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  61. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  62. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  63. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  64. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  65. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  66. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  67. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  68. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  69. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  70. Apte S, et al. 2010. J Immunol. 185:998. PubMed
  71. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  72. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  73. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  74. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  75. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  76. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  77. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  78. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  79. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  80. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  81. Treger RS, et al. 2020. Immunity. 50(2):334-347.e9.. PubMed
  82. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  83. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  84. Wu K, et al. 2021. Aging (Albany NY). 13:. PubMed
  85. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  86. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  87. Lutes LK, et al. 2021. eLife. 10:00. PubMed
  88. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  89. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  90. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  91. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  92. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  93. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  94. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  95. Morales D, et al. 2015. J Virol. 89:337. PubMed
  96. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  97. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  98. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  99. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  100. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  101. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  102. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  103. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  104. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  105. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  106. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  107. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  108. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  109. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  110. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  111. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  112. Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed
  113. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  114. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  115. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  116. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  117. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  118. Wu J, et al. 2020. Immunity. 53:115. PubMed
  119. Köchl R, et al. 2020. Elife. 9:00. PubMed
  120. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  121. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  122. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  123. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  124. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  125. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  126. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  127. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  128. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  129. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  130. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  131. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  132. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  133. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  134. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  135. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  136. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  137. Yang J, et al. 2020. Nature. 586:572. PubMed
  138. Wan X, et al. 2018. Nature. 560:107. PubMed
  139. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  140. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  141. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  142. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  143. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  144. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  145. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  146. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  147. Du J, et al. 2018. AMB Express. 8:158. PubMed
  148. Holman P, et al. 2005. J Immunol. 174:3986. PubMed
  149. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  150. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  151. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  152. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  153. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  154. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  155. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  156. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  157. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  158. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  159. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  160. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  161. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  162. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  163. Jin C, et al. 2022. Oncoimmunology. 11:2099642. PubMed
  164. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  165. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  166. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  167. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  168. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  169. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  170. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  171. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  172. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  173. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  174. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  175. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  176. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  177. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  178. Riedl P, et al. 2009. J Immunol. 183:370. PubMed
  179. Zhan L, et al. 2022. Cancer Lett. 529:37. PubMed
  180. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  181. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  182. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  183. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  184. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  185. Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed
  186. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  187. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  188. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  189. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  190. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  191. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  192. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  193. Kvell K, et al. 2014. Immunobiology. 219:644. PubMed
  194. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  195. Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed
  196. Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed
  197. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  198. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  199. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  200. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  201. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  202. Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed
  203. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  204. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  205. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  206. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  207. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  208. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  209. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  210. Ren Y, et al. 2021. Nat Commun. 12:5405. PubMed
  211. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  212. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  213. Royzman D, et al. 2019. Front Immunol. 10:633. PubMed
  214. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  215. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  216. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  217. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  218. Petriv N, et al. 2021. Oncoimmunology. 10:1874159. PubMed
  219. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  220. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  221. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  222. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  223. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  224. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  225. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  226. Li H, et al. 2022. iScience. 25:104481. PubMed
  227. Wang X, et al. 2022. Elife. 11:. PubMed
  228. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  229. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  230. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  231. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  232. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  233. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  234. Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed
  235. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  236. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  237. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  238. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  239. D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed
  240. Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed
  241. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  242. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  243. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  244. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  245. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  246. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  247. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  248. Xie L, et al. 2020. Infect Immun. :88. PubMed
  249. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  250. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  251. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  252. Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed
  253. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  254. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  255. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  256. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  257. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  258. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  259. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  260. Liu J, et al. 2019. Immunity. 50:600. PubMed
  261. Milanovic M, et al. 2021. Cancer Res. 81:426. PubMed
  262. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  263. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  264. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  265. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  266. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  267. Chowdhury S, et al. 2022. Cancer Res. 82:2640. PubMed
  268. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  269. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  270. Deng P, et al. 2022. J Clin Invest. 132: . PubMed
  271. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  272. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  273. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  274. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  275. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  276. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  277. Wang L, et al. 2022. Nutrients. 15: . PubMed
  278. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  279. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  280. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  281. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  282. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  283. Milanovic M, et al. 2021. J Immunol. 206:1228. PubMed
  284. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  285. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  286. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  287. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  288. Lee KM, et al. 2022. Cancer Immunol Res. 10:829. PubMed
  289. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  290. Alghamri MS, et al. 2022. ACS Nano. 16:8729. PubMed
  291. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  292. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  293. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  294. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  295. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  296. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  297. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  298. Bhatia V, et al. 2023. Nat Commun. 14:2041. PubMed
  299. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  300. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  301. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  302. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  303. Park HJ, et al. 2023. NPJ Vaccines. 8:84. PubMed
  304. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  305. Pagano G, et al. 2023. Haematologica. . PubMed
  306. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
  307. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  308. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  309. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  310. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  311. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  312. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  313. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  314. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  315. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  316. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  317. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  318. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  319. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  320. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  321. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  322. Apte S, et al. 2010. J Immunol. 185:998. PubMed
  323. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  324. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  325. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  326. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  327. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  328. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  329. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  330. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  331. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  332. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  333. Treger RS, et al. 2020. Immunity. 50(2):334-347.e9.. PubMed
  334. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  335. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  336. Wu K, et al. 2021. Aging (Albany NY). 13:. PubMed
  337. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  338. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  339. Lutes LK, et al. 2021. eLife. 10:00. PubMed
  340. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  341. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  342. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  343. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  344. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  345. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  346. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  347. Morales D, et al. 2015. J Virol. 89:337. PubMed
  348. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  349. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  350. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  351. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  352. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  353. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  354. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  355. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  356. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  357. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  358. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  359. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  360. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  361. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  362. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  363. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  364. Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed
  365. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  366. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  367. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  368. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  369. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  370. Wu J, et al. 2020. Immunity. 53:115. PubMed
  371. Köchl R, et al. 2020. Elife. 9:00. PubMed
  372. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  373. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  374. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  375. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  376. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  377. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  378. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  379. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  380. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  381. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  382. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  383. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  384. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  385. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  386. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  387. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  388. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  389. Yang J, et al. 2020. Nature. 586:572. PubMed
  390. Wan X, et al. 2018. Nature. 560:107. PubMed
  391. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  392. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  393. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  394. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  395. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  396. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  397. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  398. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  399. Du J, et al. 2018. AMB Express. 8:158. PubMed
  400. Holman P, et al. 2005. J Immunol. 174:3986. PubMed
  401. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  402. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  403. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  404. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  405. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  406. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  407. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  408. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  409. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  410. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  411. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  412. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  413. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  414. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  415. Jin C, et al. 2022. Oncoimmunology. 11:2099642. PubMed
  416. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  417. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  418. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  419. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  420. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  421. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  422. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  423. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  424. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  425. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  426. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  427. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  428. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  429. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  430. Riedl P, et al. 2009. J Immunol. 183:370. PubMed
  431. Zhan L, et al. 2022. Cancer Lett. 529:37. PubMed
  432. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  433. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  434. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  435. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  436. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  437. Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed
  438. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  439. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  440. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  441. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  442. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  443. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  444. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  445. Kvell K, et al. 2014. Immunobiology. 219:644. PubMed
  446. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  447. Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed
  448. Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed
  449. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  450. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  451. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  452. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  453. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  454. Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed
  455. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  456. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  457. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  458. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  459. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  460. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  461. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  462. Ren Y, et al. 2021. Nat Commun. 12:5405. PubMed
  463. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  464. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  465. Royzman D, et al. 2019. Front Immunol. 10:633. PubMed
  466. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  467. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  468. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  469. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  470. Petriv N, et al. 2021. Oncoimmunology. 10:1874159. PubMed
  471. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  472. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  473. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  474. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  475. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  476. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  477. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  478. Li H, et al. 2022. iScience. 25:104481. PubMed
  479. Wang X, et al. 2022. Elife. 11:. PubMed
  480. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  481. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  482. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  483. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  484. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  485. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  486. Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed
  487. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  488. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  489. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  490. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  491. D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed
  492. Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed
  493. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  494. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  495. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  496. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  497. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  498. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  499. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  500. Xie L, et al. 2020. Infect Immun. :88. PubMed
  501. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  502. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  503. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  504. Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed
RRID
AB_312744 (BioLegend Cat. No. 100705)
AB_312745 (BioLegend Cat. No. 100706)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
FITC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
APC anti-mouse CD8a 53-6.7 FC
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01/21/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account